Psychoactive substance use among students: A cross-sectional analysis.


Journal

Fundamental & clinical pharmacology
ISSN: 1472-8206
Titre abrégé: Fundam Clin Pharmacol
Pays: England
ID NLM: 8710411

Informations de publication

Date de publication:
Oct 2022
Historique:
revised: 17 01 2022
received: 10 08 2021
accepted: 21 02 2022
pubmed: 24 2 2022
medline: 14 9 2022
entrez: 23 2 2022
Statut: ppublish

Résumé

Little is known about psychoactive substance use in students, apart from tobacco, alcohol, and cannabis. This study investigated the prevalence of substance use and overlap between various psychoactive substances in students. This cross-sectional study was conducted in 10 066 students included in the i-Share cohort between January 1, 2015, and December 31, 2017. The baseline questionnaire was the key source of information. Psychoactive substances of interest (PSI) were cannabis, cocaine, amphetamines, nitrous oxide, poppers, and MDMA. Their patterns of use were categorized as lifetime, past year, and current use. The use of other psychoactive substances including alcohol and tobacco was described in PSI users and non-users. Most participants were female (75%), and their average age was 21 years. Lifetime use of at least one PSI was reported by 65.5% of participants. Cannabis was the most frequently used substance both over lifetime (57% of students) and past year (35%), followed by poppers and nitrous oxide (28% and 26% of students over lifetime, respectively). Among polydrug users (n = 1242), 65% used only nitrous oxide and poppers, showing a strong link between these two substances. Regular alcohol use, binge drinking, and current tobacco use were higher in PSI users than in non-users. Substance use was higher than previously found in both French and European studies in young people. Nitrous oxide use was particularly high. Regular alcohol use, binge drinking, and tobacco use could be used as markers to identify students at risk of PSI use to be targeted by prevention programs.

Identifiants

pubmed: 35194825
doi: 10.1111/fcp.12771
pmc: PMC9544725
doi:

Substances chimiques

Ethanol 3K9958V90M
Nitrous Oxide K50XQU1029

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

908-914

Subventions

Organisme : French National Research Agency
ID : ANR-10-COHO-05
Organisme : Health Determinants in Societies
ID : ANR-10-IDEX-03-02

Informations de copyright

© 2022 The Authors. Fundamental & Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of Société Française de Pharmacologie et de Thérapeutique.

Références

Lancet. 2007 Mar 24;369(9566):1047-53
pubmed: 17382831
Drug Alcohol Depend. 2020 Apr 1;209:107894
pubmed: 32126453
Fundam Clin Pharmacol. 2022 Oct;36(5):908-914
pubmed: 35194825
Aust N Z J Psychiatry. 2007 Aug;41(8):649-55
pubmed: 17620161
Fundam Clin Pharmacol. 2021 Apr;35(2):455-465
pubmed: 32854152
Drug Alcohol Depend. 2019 Dec 1;205:107589
pubmed: 31605958
Curr Pharm Biotechnol. 2010 Aug;11(5):470-5
pubmed: 20420571
J Am Heart Assoc. 2014 Apr 23;3(2):e000638
pubmed: 24760961
Addiction. 1994 Jul;89(7):831-9
pubmed: 8081181
Drug Alcohol Depend. 2019 Aug 1;201:23-28
pubmed: 31174141
Eur Psychiatry. 2017 Sep;45:221-226
pubmed: 28957791
Therapie. 2021 Sep-Oct;76(5):478-479
pubmed: 32063400
Alcohol Clin Exp Res. 2005 Nov;29(11):2001-7
pubmed: 16340457
Drug Alcohol Depend. 2020 Mar 1;208:107867
pubmed: 31958677
BMC Psychiatry. 2018 Nov 27;18(1):373
pubmed: 30482174
Int J Environ Res Public Health. 2017 Nov 05;14(11):
pubmed: 29113070
Curr Atheroscler Rep. 2017 Jun;19(6):26
pubmed: 28432636
Schizophr Res. 2005 Nov 1;79(1):69-75
pubmed: 16198239

Auteurs

Justine Perino (J)

Department of Medical Pharmacology, Centre d'addictovigilance de Bordeaux, Bordeaux, France.
Univ. Bordeaux, INSERM U1219, Bordeaux Population Health Research Center, Bordeaux, France.
CHU de Bordeaux, Bordeaux, France.

Marie Tournier (M)

Univ. Bordeaux, INSERM U1219, Bordeaux Population Health Research Center, Bordeaux, France.
Hospital Charles Perrens, Bordeaux, France.

Clément Mathieu (C)

Univ. Bordeaux, INSERM U1219, Bordeaux Population Health Research Center, Bordeaux, France.

Louis Letinier (L)

Univ. Bordeaux, INSERM U1219, Bordeaux Population Health Research Center, Bordeaux, France.
CHU de Bordeaux, Bordeaux, France.

Alexandre Peyré (A)

Department of Medical Pharmacology, Centre d'addictovigilance de Bordeaux, Bordeaux, France.
CHU de Bordeaux, Bordeaux, France.

Garance Perret (G)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team HEALTHY, Bordeaux, France.

Edwige Pereira (E)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team HEALTHY, Bordeaux, France.

Annie Fourrier-Réglat (A)

Univ. Bordeaux, INSERM U1219, Bordeaux Population Health Research Center, Bordeaux, France.
CHU de Bordeaux, Bordeaux, France.

Clothilde Pollet (C)

Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team HEALTHY, Bordeaux, France.

Mélina Fatseas (M)

CHU de Bordeaux, Bordeaux, France.
University of Bordeaux, Institut de Neurosciences Cognitives et Intégratives d'Aquitaine (INCIA), Bordeaux, France.

Christophe Tzourio (C)

CHU de Bordeaux, Bordeaux, France.
Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, Team HEALTHY, Bordeaux, France.

Amélie Daveluy (A)

Department of Medical Pharmacology, Centre d'addictovigilance de Bordeaux, Bordeaux, France.
Univ. Bordeaux, INSERM U1219, Bordeaux Population Health Research Center, Bordeaux, France.
CHU de Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH